CN109985022B - 聚维酮碘制剂及其制备方法和用途 - Google Patents
聚维酮碘制剂及其制备方法和用途 Download PDFInfo
- Publication number
- CN109985022B CN109985022B CN201910199016.2A CN201910199016A CN109985022B CN 109985022 B CN109985022 B CN 109985022B CN 201910199016 A CN201910199016 A CN 201910199016A CN 109985022 B CN109985022 B CN 109985022B
- Authority
- CN
- China
- Prior art keywords
- povidone
- iodine
- povidone iodine
- parts
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- CPKVUHPKYQGHMW-UHFFFAOYSA-N 1-ethenylpyrrolidin-2-one;molecular iodine Chemical compound II.C=CN1CCCC1=O CPKVUHPKYQGHMW-UHFFFAOYSA-N 0.000 title claims abstract description 240
- 229920000153 Povidone-iodine Polymers 0.000 title claims abstract description 239
- 229960001621 povidone-iodine Drugs 0.000 title claims abstract description 239
- 238000002360 preparation method Methods 0.000 title claims abstract description 105
- 238000000034 method Methods 0.000 title claims description 23
- 239000000843 powder Substances 0.000 claims abstract description 89
- 239000002775 capsule Substances 0.000 claims abstract description 87
- 239000011162 core material Substances 0.000 claims abstract description 87
- 238000002156 mixing Methods 0.000 claims abstract description 25
- 239000011248 coating agent Substances 0.000 claims abstract description 21
- 238000000576 coating method Methods 0.000 claims abstract description 21
- 230000002265 prevention Effects 0.000 claims abstract description 21
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims abstract description 19
- 229910052740 iodine Inorganic materials 0.000 claims abstract description 19
- 239000011630 iodine Substances 0.000 claims abstract description 19
- 238000011282 treatment Methods 0.000 claims abstract description 19
- 239000000463 material Substances 0.000 claims abstract description 16
- 239000002535 acidifier Substances 0.000 claims abstract description 15
- 238000007865 diluting Methods 0.000 claims abstract description 14
- 239000002994 raw material Substances 0.000 claims abstract description 14
- 238000004519 manufacturing process Methods 0.000 claims abstract description 8
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 40
- 239000000661 sodium alginate Substances 0.000 claims description 40
- 235000010413 sodium alginate Nutrition 0.000 claims description 40
- 229940005550 sodium alginate Drugs 0.000 claims description 40
- 206010012735 Diarrhoea Diseases 0.000 claims description 27
- 239000000203 mixture Substances 0.000 claims description 24
- 238000009472 formulation Methods 0.000 claims description 23
- 239000003814 drug Substances 0.000 claims description 22
- 239000004005 microsphere Substances 0.000 claims description 22
- 239000003963 antioxidant agent Substances 0.000 claims description 20
- 230000003078 antioxidant effect Effects 0.000 claims description 20
- 239000003381 stabilizer Substances 0.000 claims description 20
- 235000019871 vegetable fat Nutrition 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- 244000309466 calf Species 0.000 claims description 18
- 239000002245 particle Substances 0.000 claims description 17
- 208000005342 Porcine Reproductive and Respiratory Syndrome Diseases 0.000 claims description 15
- 201000010099 disease Diseases 0.000 claims description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 13
- 239000003674 animal food additive Substances 0.000 claims description 12
- 238000005507 spraying Methods 0.000 claims description 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 6
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 6
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 6
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 6
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 4
- 229920000623 Cellulose acetate phthalate Polymers 0.000 claims description 4
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 claims description 4
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 4
- 229920001800 Shellac Polymers 0.000 claims description 4
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 4
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 4
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 4
- 229940081734 cellulose acetate phthalate Drugs 0.000 claims description 4
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 4
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 4
- 229960003943 hypromellose Drugs 0.000 claims description 4
- 239000004208 shellac Substances 0.000 claims description 4
- 229940113147 shellac Drugs 0.000 claims description 4
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 claims description 4
- 235000013874 shellac Nutrition 0.000 claims description 4
- 230000003612 virological effect Effects 0.000 claims description 3
- 241000271566 Aves Species 0.000 claims description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 2
- 239000001530 fumaric acid Substances 0.000 claims description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 claims description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 claims description 2
- 239000011347 resin Substances 0.000 claims 2
- 229920005989 resin Polymers 0.000 claims 2
- 230000001580 bacterial effect Effects 0.000 claims 1
- 238000011321 prophylaxis Methods 0.000 claims 1
- 239000000243 solution Substances 0.000 abstract description 45
- 241000700605 Viruses Species 0.000 abstract description 23
- 241001465754 Metazoa Species 0.000 abstract description 22
- 229960005486 vaccine Drugs 0.000 abstract description 21
- 230000000694 effects Effects 0.000 abstract description 16
- 238000002347 injection Methods 0.000 abstract description 7
- 239000007924 injection Substances 0.000 abstract description 7
- 108090000623 proteins and genes Proteins 0.000 abstract description 6
- 238000009395 breeding Methods 0.000 abstract description 5
- 230000001488 breeding effect Effects 0.000 abstract description 5
- 102000004169 proteins and genes Human genes 0.000 abstract description 5
- 239000000126 substance Substances 0.000 abstract description 5
- 238000009776 industrial production Methods 0.000 abstract description 4
- 238000003860 storage Methods 0.000 abstract description 4
- 206010011409 Cross infection Diseases 0.000 abstract description 3
- 206010029803 Nosocomial infection Diseases 0.000 abstract description 3
- 241000283690 Bos taurus Species 0.000 description 18
- 238000012360 testing method Methods 0.000 description 18
- 238000001035 drying Methods 0.000 description 16
- 230000003115 biocidal effect Effects 0.000 description 13
- 241000894006 Bacteria Species 0.000 description 11
- 239000003242 anti bacterial agent Substances 0.000 description 10
- 229940088710 antibiotic agent Drugs 0.000 description 10
- 230000006378 damage Effects 0.000 description 10
- 210000001035 gastrointestinal tract Anatomy 0.000 description 10
- 241001135989 Porcine reproductive and respiratory syndrome virus Species 0.000 description 9
- 230000002354 daily effect Effects 0.000 description 9
- 230000002147 killing effect Effects 0.000 description 9
- 241000282898 Sus scrofa Species 0.000 description 8
- 238000001125 extrusion Methods 0.000 description 8
- 238000005563 spheronization Methods 0.000 description 8
- 239000004925 Acrylic resin Substances 0.000 description 6
- 229920000178 Acrylic resin Polymers 0.000 description 6
- 241000282887 Suidae Species 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 241000233866 Fungi Species 0.000 description 5
- 210000004185 liver Anatomy 0.000 description 5
- 241000588724 Escherichia coli Species 0.000 description 4
- 241000287828 Gallus gallus Species 0.000 description 4
- 241000607142 Salmonella Species 0.000 description 4
- 206010051511 Viral diarrhoea Diseases 0.000 description 4
- 206010000210 abortion Diseases 0.000 description 4
- 231100000176 abortion Toxicity 0.000 description 4
- 235000013330 chicken meat Nutrition 0.000 description 4
- 239000006185 dispersion Substances 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 239000000178 monomer Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- 208000035143 Bacterial infection Diseases 0.000 description 3
- 208000027954 Poultry disease Diseases 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 208000029182 enterotoxemia Diseases 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 230000002458 infectious effect Effects 0.000 description 3
- 230000003907 kidney function Effects 0.000 description 3
- 230000003908 liver function Effects 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 2
- 241000701386 African swine fever virus Species 0.000 description 2
- 241000711573 Coronaviridae Species 0.000 description 2
- 208000002979 Influenza in Birds Diseases 0.000 description 2
- 208000009525 Myocarditis Diseases 0.000 description 2
- 241001135549 Porcine epidemic diarrhea virus Species 0.000 description 2
- 241000711484 Transmissible gastroenteritis virus Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000002155 anti-virotic effect Effects 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 206010064097 avian influenza Diseases 0.000 description 2
- 208000022362 bacterial infectious disease Diseases 0.000 description 2
- 239000000645 desinfectant Substances 0.000 description 2
- 230000000249 desinfective effect Effects 0.000 description 2
- 239000003651 drinking water Substances 0.000 description 2
- 235000020188 drinking water Nutrition 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000003238 esophagus Anatomy 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 2
- 229920003132 hydroxypropyl methylcellulose phthalate Polymers 0.000 description 2
- 229940031704 hydroxypropyl methylcellulose phthalate Drugs 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000008774 maternal effect Effects 0.000 description 2
- 244000000010 microbial pathogen Species 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000007918 pathogenicity Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 208000026775 severe diarrhea Diseases 0.000 description 2
- 230000006641 stabilisation Effects 0.000 description 2
- 238000011105 stabilization Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 239000003981 vehicle Substances 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 241000186361 Actinobacteria <class> Species 0.000 description 1
- 241000711404 Avian avulavirus 1 Species 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 241000193403 Clostridium Species 0.000 description 1
- 241000224483 Coccidia Species 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 206010018691 Granuloma Diseases 0.000 description 1
- 206010053759 Growth retardation Diseases 0.000 description 1
- 241000588748 Klebsiella Species 0.000 description 1
- 208000001572 Mycoplasma Pneumonia Diseases 0.000 description 1
- 201000008235 Mycoplasma pneumoniae pneumonia Diseases 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 208000010359 Newcastle Disease Diseases 0.000 description 1
- 101710144128 Non-structural protein 2 Proteins 0.000 description 1
- 241000606860 Pasteurella Species 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 241000702665 Porcine rotavirus Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 102100022648 Reticulon-2 Human genes 0.000 description 1
- 206010051497 Rhinotracheitis Diseases 0.000 description 1
- 241000702670 Rotavirus Species 0.000 description 1
- 208000007893 Salpingitis Diseases 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 208000032625 disorder of ear Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 206010014801 endophthalmitis Diseases 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 231100000001 growth retardation Toxicity 0.000 description 1
- 231100000086 high toxicity Toxicity 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 201000009837 laryngotracheitis Diseases 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 206010030306 omphalitis Diseases 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000004798 organs belonging to the digestive system Anatomy 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 206010034674 peritonitis Diseases 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 235000013594 poultry meat Nutrition 0.000 description 1
- 229940069328 povidone Drugs 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 201000004595 synovitis Diseases 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 241001529453 unidentified herpesvirus Species 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/105—Aliphatic or alicyclic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
- A23K20/132—Heterocyclic compounds containing only one nitrogen as hetero atom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/158—Fatty acids; Fats; Products containing oils or fats
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/163—Sugars; Polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
- A23K20/26—Compounds containing phosphorus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
- A23K20/30—Oligoelements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/60—Feeding-stuffs specially adapted for particular animals for weanlings
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
- A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/18—Iodine; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
- A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910199016.2A CN109985022B (zh) | 2019-03-15 | 2019-03-15 | 聚维酮碘制剂及其制备方法和用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910199016.2A CN109985022B (zh) | 2019-03-15 | 2019-03-15 | 聚维酮碘制剂及其制备方法和用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109985022A CN109985022A (zh) | 2019-07-09 |
CN109985022B true CN109985022B (zh) | 2021-03-23 |
Family
ID=67130458
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910199016.2A Active CN109985022B (zh) | 2019-03-15 | 2019-03-15 | 聚维酮碘制剂及其制备方法和用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109985022B (zh) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103720640A (zh) * | 2013-12-31 | 2014-04-16 | 哈尔滨欧替药业有限公司 | 聚维酮碘阴道膨胀栓及其制备方法和检测方法 |
CN105311049A (zh) * | 2014-06-15 | 2016-02-10 | 江苏三仪胜意药业有限公司 | 一种兽用聚维酮碘消毒液的制备方法 |
CN105640916A (zh) * | 2016-02-22 | 2016-06-08 | 上海宇昂水性新材料科技股份有限公司 | 兼具抗菌、护肤消炎作用的聚维酮碘泡腾片及其生产工艺 |
WO2017174796A1 (de) * | 2016-04-08 | 2017-10-12 | Dietrich Seidel | Mittel zur verwendung bei entzündlichen zuständen der schleimhäute |
CN108670948A (zh) * | 2018-05-04 | 2018-10-19 | 江西新天地药业有限公司 | 一种纳米级微囊单分子聚维酮碘溶液及其制备方法 |
-
2019
- 2019-03-15 CN CN201910199016.2A patent/CN109985022B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103720640A (zh) * | 2013-12-31 | 2014-04-16 | 哈尔滨欧替药业有限公司 | 聚维酮碘阴道膨胀栓及其制备方法和检测方法 |
CN105311049A (zh) * | 2014-06-15 | 2016-02-10 | 江苏三仪胜意药业有限公司 | 一种兽用聚维酮碘消毒液的制备方法 |
CN105640916A (zh) * | 2016-02-22 | 2016-06-08 | 上海宇昂水性新材料科技股份有限公司 | 兼具抗菌、护肤消炎作用的聚维酮碘泡腾片及其生产工艺 |
WO2017174796A1 (de) * | 2016-04-08 | 2017-10-12 | Dietrich Seidel | Mittel zur verwendung bei entzündlichen zuständen der schleimhäute |
CN108670948A (zh) * | 2018-05-04 | 2018-10-19 | 江西新天地药业有限公司 | 一种纳米级微囊单分子聚维酮碘溶液及其制备方法 |
Non-Patent Citations (1)
Title |
---|
Production and Characterization of Biodegradable Povidone-iodine Microsphere as a Intramammary Disinfectant;Park,HM等;《Journal of veterinary medical science》;20020831;第64卷(第8期);文章摘要 * |
Also Published As
Publication number | Publication date |
---|---|
CN109985022A (zh) | 2019-07-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4664678B2 (ja) | 抗菌性組成物および使用のための方法 | |
Hofacre et al. | Antimicrobial drug use in poultry | |
CN111705042A (zh) | 一株巴氏杆菌噬菌体vB_PmuP_PS02、其噬菌体组合物及其应用 | |
KR100707997B1 (ko) | 가축용 사료 및 이를 이용한 가축 사육 방법 | |
CN113273646B (zh) | 一种母猪分娩接生用粉剂及其制备方法和应用 | |
CN105534912A (zh) | 一种高稳定性的盐酸沃尼妙林可溶性粉及其用途 | |
CN116635049A (zh) | 抗微生物剂组成物和制造方法及其产品 | |
CN110201142A (zh) | 一种用于防治鸡输卵管炎的复方制剂及其制备方法 | |
WO2013000093A1 (en) | Location-specific bacterial management | |
CN109985022B (zh) | 聚维酮碘制剂及其制备方法和用途 | |
JPH03198747A (ja) | 牛,豚用の抗病性飼料および飼料用添加物 | |
US10905748B2 (en) | Ovotransferrin treatment for the reproductive tract | |
CN102764252A (zh) | 一种盐酸沃尼妙林的用途 | |
JP2002507123A (ja) | プロバイオティックの有効性を改良する方法、栄養添加物の調製、およびそれを含む動物飼料 | |
JPH119196A (ja) | キトサンによる家畜の損耗防止の方法 | |
JPH0656689A (ja) | 感染性下痢症予防及び治療用組成物 | |
CN112586610A (zh) | 一种抗生素替代疗法的延长释放配方 | |
CN108888762A (zh) | 一种含益生菌代谢产物的组合物 | |
RU2524664C1 (ru) | Способ профилактики массовых желудочно-кишечных и респираторных болезней молочных поросят | |
RU2792118C1 (ru) | Способ лечения респираторно-синцитиальной инфекции крупного рогатого скота | |
JP7444707B2 (ja) | 家畜の初乳品質改善剤及び方法 | |
CN115444074A (zh) | 一种槲皮素复方中药饲料添加剂及其制备方法和应用 | |
CN117378706A (zh) | 一种提高动物抗病能力的饲料添加剂及其应用 | |
CN115500432A (zh) | 一种用于防治畜禽细菌性疾病的颗粒剂及其制备方法 | |
CN106615819A (zh) | 防控仔猪腹泻的无抗添加剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20200706 Address after: Room 602-01, 6th floor, 109 Hexing Road, Nangang District, Harbin City, Heilongjiang Province Applicant after: Harbin tianlinjian Bioengineering Co.,Ltd. Address before: 150000 Minjiang District, Nangang District, Harbin City, Heilongjiang Province Applicant before: Harbin Datang Biotechnology Co.,Ltd. |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CB03 | Change of inventor or designer information |
Inventor after: Ma Qiang Inventor after: Cui Liu Inventor after: Ma Ruicong Inventor before: Ma Qiang |
|
CB03 | Change of inventor or designer information | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240705 Address after: B124, 1st Floor, Building 1, No. 55 Pingshun Street, Harbin Economic Development Zone, Heilongjiang Province, 150090 Patentee after: Harbin Hongyao Biological Engineering Co.,Ltd. Country or region after: China Address before: Room 602-01, 6th floor, 109 Hexing Road, Nangang District, Harbin City, Heilongjiang Province Patentee before: Harbin tianlinjian Bioengineering Co.,Ltd. Country or region before: China |
|
TR01 | Transfer of patent right |